Biotech · Private company
Memgen, Inc.
Track this companyFree. Adds Memgen, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- DocetaxelPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- ISF35Phase 1 · Chronic Lymphocytic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- MEM-288 Intratumoral InjectionPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid TumorsPHASE1 · RECRUITING · started Apr 21, 2022ClinicalTrials.gov NCT05076760 · fetched Nov 12, 2026
- A Phase Ib Study of ISF35 in Combination With Chemotherapy (FCR) in Subjects With Relapsed, Refractory, and/or 17p- CLLPHASE1 · COMPLETED · started Sep 1, 2008ClinicalTrials.gov NCT00772486 · fetched Nov 12, 2026